CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 5.75 HKD -3.36% Market Closed
Market Cap: 8.5B HKD

Wall Street
Price Targets

Price Targets Summary
CStone Pharmaceuticals

Wall Street analysts forecast CStone Pharmaceuticals stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 13.93 HKD with a low forecast of 7.38 HKD and a high forecast of 21 HKD.

Lowest
Price Target
7.38 HKD
28% Upside
Average
Price Target
13.93 HKD
142% Upside
Highest
Price Target
21 HKD
265% Upside
CStone Pharmaceuticals Competitors:
Price Targets
ARMP
Armata Pharmaceuticals Inc
59% Upside
VCEL
Vericel Corp
52% Upside
TVTX
Travere Therapeutics Inc
21% Upside
RNA
Avidity Biosciences Inc
3% Upside
VTVT
vTv Therapeutics Inc
11% Upside
SCLP
Scancell Holdings PLC
219% Upside
CLYM
Climb Bio Inc
308% Upside

Revenue
Forecast

Revenue Estimate
CStone Pharmaceuticals

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 20%.

N/A
Past Growth
20%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
CStone Pharmaceuticals

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CStone Pharmaceuticals's stock price target?
Price Target
13.93 HKD

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 13.93 HKD with a low forecast of 7.38 HKD and a high forecast of 21 HKD.

What is CStone Pharmaceuticals's Revenue forecast?
Projected CAGR
20%

The compound annual growth rate of CStone Pharmaceuticals's revenue for the next 3 years is 20%.

Back to Top